Coral Laboratories Ltd

Coral Laboratories Ltd

₹ 502 0.36%
16 Jun - close price
About

Incorporated in 1994, Coral Laboratories Ltd is in the business of pharmaceutical formulations[1]

Key Points

Business Overview:[1]
CLL is an ISO 9001:2008 certified manufacturer and exporter of pharmaceutical formulations like tablets, capsules, liquid, and topical preparations. It focuses on generics, troubleshooting existing products, and patent noninfringing products for emerging markets.

  • Market Cap 179 Cr.
  • Current Price 502
  • High / Low 625 / 360
  • Stock P/E 11.1
  • Book Value 585
  • Dividend Yield 0.30 %
  • ROCE 11.0 %
  • ROE 7.88 %
  • Face Value 10.0

Pros

  • Company is almost debt free.
  • Stock is trading at 0.86 times its book value

Cons

  • The company has delivered a poor sales growth of -2.31% over past five years.
  • Company has a low return on equity of 10.1% over last 3 years.
  • Earnings include an other income of Rs.10.2 Cr.
  • Working capital days have increased from 217 days to 328 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
11.44 13.55 23.15 18.08 28.89 31.66 32.23 22.99 28.13 18.82 19.03 21.56 26.48
13.52 11.81 17.00 15.98 22.64 20.92 25.72 16.67 25.44 16.64 14.09 19.67 20.28
Operating Profit -2.08 1.74 6.15 2.10 6.25 10.74 6.51 6.32 2.69 2.18 4.94 1.89 6.20
OPM % -18.18% 12.84% 26.57% 11.62% 21.63% 33.92% 20.20% 27.49% 9.56% 11.58% 25.96% 8.77% 23.41%
1.16 1.29 1.81 1.37 2.00 1.56 2.54 2.52 1.71 2.05 3.03 2.49 2.64
Interest 0.02 0.00 0.00 0.00 0.00 0.03 0.01 0.02 0.04 0.06 0.10 0.00 0.01
Depreciation 0.68 0.55 0.44 0.49 0.50 0.49 0.51 0.50 0.51 0.45 0.45 0.69 0.54
Profit before tax -1.62 2.48 7.52 2.98 7.75 11.78 8.53 8.32 3.85 3.72 7.42 3.69 8.29
Tax % -45.06% 26.21% 20.21% 27.52% 25.16% 25.21% 25.21% 26.08% 26.49% 31.18% 21.56% 24.93% 36.91%
-0.89 1.84 6.00 2.16 5.79 8.80 6.38 6.14 2.83 2.56 5.82 2.78 5.22
EPS in Rs -2.49 5.15 16.79 6.05 16.21 24.63 17.86 17.19 7.92 7.17 16.29 7.78 14.61
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
59 77 95 92 91 71 97 76 78 84 115 86
47 60 72 77 79 65 81 67 74 67 89 71
Operating Profit 12 16 23 15 12 5 16 8 4 16 26 15
OPM % 21% 21% 24% 17% 14% 8% 16% 11% 5% 19% 23% 18%
3 3 3 4 5 6 4 6 7 6 8 10
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 3 2 2 2 2 2 2 2 2 2 2 2
Profit before tax 12 17 25 18 16 9 18 12 8 21 32 23
Tax % 22% 29% 34% 31% 34% 22% 23% 24% 22% 24% 26% 29%
10 12 16 12 10 7 14 9 6 16 24 16
EPS in Rs 26.79 34.71 45.63 34.85 28.61 19.96 37.93 25.33 18.05 44.20 67.63 45.85
Dividend Payout % 9% 9% 11% 6% 7% 0% 0% 0% 0% 0% 0% 4%
Compounded Sales Growth
10 Years: 1%
5 Years: -2%
3 Years: 3%
TTM: -25%
Compounded Profit Growth
10 Years: 3%
5 Years: 4%
3 Years: 36%
TTM: -35%
Stock Price CAGR
10 Years: 1%
5 Years: 1%
3 Years: 27%
1 Year: -16%
Return on Equity
10 Years: 9%
5 Years: 8%
3 Years: 10%
Last Year: 8%

Balance Sheet

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 4 4 4 4 4 4 4 4 4 4 4 4
Reserves 56 67 106 113 110 112 133 152 151 174 198 206
1 0 2 2 1 6 6 6 0 0 4 4
12 19 20 22 21 23 25 28 20 28 25 27
Total Liabilities 72 89 131 140 136 144 168 190 174 206 229 241
19 18 18 22 23 23 21 24 25 24 23 44
CWIP 0 0 0 0 0 0 0 2 0 0 2 0
Investments 1 5 39 45 28 25 33 46 41 50 52 46
52 67 74 73 84 97 112 118 108 132 152 150
Total Assets 72 89 131 140 136 144 168 190 174 206 229 241

Cash Flows

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0 5 11 13 -1 -4 1 6 13 -5 -1 16
-0 -3 -10 -13 3 -2 -0 -6 -3 1 -0 -18
-0 -0 0 -3 -1 4 0 0 -6 0 3 0
Net Cash Flow -0 2 1 -2 1 -2 1 0 4 -4 1 -2
Free Cash Flow -1 4 9 9 -4 -5 -0 1 11 -6 -4 -5
CFO/OP 30% 70% 85% 124% 31% -59% 28% 127% 383% -4% 23% 150%

Ratios

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 152 132 117 125 122 178 148 184 109 123 107 125
Inventory Days 110 110 155 120 116 176 158 169 100 149 68 211
Days Payable 66 80 75 87 91 129 108 81 34 130 46 103
Cash Conversion Cycle 196 162 197 157 146 225 198 272 176 142 129 233
Working Capital Days 194 179 164 161 171 241 178 222 221 183 140 328
ROCE % 22% 27% 28% 16% 13% 8% 13% 7% 5% 13% 17% 11%

Insights

In beta
Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Export Share of Revenue
%

Log in to view insights

Please log in to see hidden values.

Login
Number of Manufacturing Plants
Number
Number of Permanent Employees
Number
Electricity Consumption (Utility Indirect Volume)
Lakh Units

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
71.51% 71.51% 71.51% 71.51% 71.51% 71.51% 71.51% 71.51% 71.51% 71.51% 71.51% 71.51%
0.14% 0.14% 0.14% 0.14% 0.23% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
28.35% 28.34% 28.35% 28.35% 28.26% 28.50% 28.49% 28.49% 28.50% 28.49% 28.48% 28.49%
No. of Shareholders 4,0403,9814,0054,0983,8313,9494,0544,1054,2134,2864,2084,084

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents